Hashimoto's thyroiditis: cytodiagnostic accuracy and pitfalls

Hashimoto's thyroiditis is a common autoimmune disorder affecting thyroid function. Prior research has shown that diagnostic methods often rely on clinical presentation and serological markers. However, the accuracy of fine-needle aspiration biopsy (NAB) in diagnosing HT remains unclear. This uncertainty drove the need for a focused study on diagnostic accuracy. While clinical suspicion and antibody testing are standard, they may not fully capture cytologic variability. No prior work had resolved the diagnostic reliability of NAB in HT cases with nodules. This gap motivated an analysis of cytodiagnostic outcomes in a large patient cohort. The study aimed to clarify diagnostic accuracy and identify potential pitfalls. Understanding these limitations could improve clinical decision-making in thyroid disease management.

The aim of this study was to evaluate the diagnostic accuracy of fine-needle aspiration biopsy for Hashimoto's thyroiditis. Researchers focused on patients with suspected or confirmed HT to determine how reliable cytodiagnosis is in this population. The specific problem addressed was the potential misdiagnosis of thyroid nodules as neoplasms when HT is the underlying condition. This study sought to clarify diagnostic reliability in both diffuse and nodular thyroid presentations. The motivation stemmed from the need to reduce diagnostic uncertainty in patients with thyroid enlargement or nodules. By reviewing a large cohort, the researchers aimed to quantify diagnostic accuracy and identify common errors. The study also aimed to highlight limitations in distinguishing benign from malignant nodules in HT patients. This work could help refine diagnostic protocols in clinical practice.

The researchers reviewed medical records and cytology samples from 146 patients with suspected or confirmed Hashimoto's thyroiditis. Fine-needle aspiration biopsies were performed on thyroid lobes or nodules based on clinical presentation. Patients were divided into two groups: those with diffuse enlargement and those with prominent nodules. Cytodiagnosis of HT was made in 134 cases after the first biopsy attempt. For patients with nodules, clinical suspicion of neoplasm was based on nodule growth patterns. Cytologic diagnoses included follicular neoplasm and Hürthle cell tumor in some cases. Histologic confirmation was obtained through thyroid surgery in 16 patients. The diagnostic accuracy was calculated based on the agreement between cytology and histology.

The diagnostic accuracy of fine-needle aspiration biopsy for Hashimoto's thyroiditis was 92% in the first biopsy attempt. Among 134 patients, cytodiagnosis of HT was confirmed histologically. In 16 patients with thyroid surgery, no tumor was found despite initial suspicion. Five patients with follicular neoplasm diagnoses had benign or malignant nodules confirmed. Seven patients diagnosed with Hürthle cell tumor had benign or non-neoplastic findings. Three cases of Hürthle cell tumor were confirmed histologically. Two patients had hyperplastic Hürthle cell nodules, and one had a benign colloid nodule. The study found that cytologic differentiation between benign and malignant nodules in HT patients is challenging.

The authors concluded that fine-needle aspiration biopsy is highly sensitive for diagnosing Hashimoto's thyroiditis. The diagnostic accuracy rate of 92% supports the use of NAB in HT evaluation. However, the study also highlighted limitations in cytodiagnosis of thyroid nodules in HT patients. Distinguishing between hyperplastic follicular nodules and follicular neoplasms is not always possible. Similarly, differentiating between hyperplastic Hürthle cell nodules and Hürthle cell tumors is difficult. These findings suggest that clinical correlation and histologic confirmation may be necessary in some cases. The study does not propose new treatment strategies or diagnostic tools. The results emphasize the importance of careful interpretation of cytology in HT patients.